Delivery Order SPE2DB20D3104-SPE2DB25FV8L2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a ceiling value of $7,625.80. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The delivery order is scheduled for completion by August 5, 2025, with...
- The Defense Logistics Agency awarded a delivery order valued at $2,178.52 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on June 24, 2025, with completion targeted for June 25, 2025. This competitively awarded, firm fixed-price delivery order represents fulfillment under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injections with a contract ceiling value of $7,412.22 and an ultimate completion date of August 27, 2025. This non-set-aside, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The order will be fulfilled from the vendor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $16,124.42 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed price contract carries an ultimate completion date of July 21, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injectors in 0.5 mL quantities, with a contract ceiling value of $8,359.40 and an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and veteran healthcare...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $3,431.61 on August 21, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's larger relationship...
- The Defense Logistics Agency awarded a $6,392.26 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for Zepbound 7.5 mg/0.5 ml pen injections. This contract represents a firm fixed price delivery order with an ultimate completion date of June 3, 2025, and was awarded through open competition without set-aside designation. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $10,814.13 firm fixed price delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pen injectors with a completion date of June 2, 2025. This non-set-aside competitive award represents a continuation of services under AmerisourceBergen's broader pharmaceutical supply arrangement with the federal government. The delivery order is being fulfilled from the company's place of business in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections with a ceiling value of $1,143.87 and an ultimate completion date of November 10, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound 12.5 mg/0.5 ml pen injections with a ceiling value of $1,525.16. This is a firm fixed price delivery order with an ultimate completion date of September 4, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV8L2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Zepbound 15 mg/0.5 ml pen injections, with a ceiling value of $14,363.78 and an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply role within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary distribution hub. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical commodities to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its critical role as a pharmaceutical distributor for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with consistent delivery order awards across multiple therapeutic domains including specialty medications, vaccines, and medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 6/25/25 |